Intel (NASDAQ:INTC) Health Guide Software Monitoring Health

Intel (NASDAQ:INTC) and General Electric Co. have won FDA approval for Intel (NASDAQ:INTC) Health Guide. Intel (NASDAQ:INTC) Health Guide Software Monitoring Health Intel (NASDAQ:INTC)-GE Care Innovations, a joint venture of Intel (NASDAQ:INTC) and GE, has received U.S. Food and Drug Administration 510(k) clearance for the Intel (NASDAQ:INTC) Health Guide Express. This is a software solution that combines in-home monitoring, patient education, and online provider consultation capabilities to improve chronic disease management. Louis Burns, the CEO of Intel (NASDAQ:INTC)-GE Care Innovations said that, “With this new platform, Intel-GE Care Innovations facilitates greater care coordination that gives healthcare organizations the ability to innovate and provide customized care." Intel Corp. (NASDAQ:INTC) shares are currently standing at 21.79. Price History Last Price: 21.79 52 Week Low / High: 17.6 / 24.37 50 Day Moving Average: 21.31 6 Month Price Change %: 18.5% 12 Month Price Change %: 3.8%
Negocioenlinea
tdp2664
E money daily